Author:
Bhattacharya Sujit K.,Ghosal Ajanta,Ganguly Sudeshna,Ganguly Sandipan,Azim Sabahat,Dutta Shanta
Reference36 articles.
1. WHO/Department of Control of Neglected Tropical Diseases. Global leishmaniasis update, 2006–2015: A turning point in leishmaniasis surveillance. Weekly Epidemiological Record. 2017;92:557-572
2. WHO. South-East Asia poised to defeat visceral leishmaniasis (kala-azar). 2015. Available from: http://www.who.int/neglected_diseases/news/SEARO_poised_to_defeat_VL/en /
3. Desjeux P, Ghosh RS, Dhalaria P, Strub-Wourgaft N, Zijlstra E. Report of the post kala-azar dermal Leishmaniasis (PKDL) consortium meeting, New Delhi, India, 27–29 June 2012. Parasites & Vectors. 2013;6:196. DOI: 10.1186/1756-3305-6-196
4. Musa AM, Khalil EAG, Younis BM, Elfaki MEE, Elamin MY, Adam AOA, Mohamed HAA, Dafalla MMM, Abuzaid AA, El-Hassan AM. Treatment-based strategy for the management of post-kala-azar dermal leishmaniasis patients in the Sudan. Journal of Tropical Medicine. 2013;2013:1-5. Article ID: 708391. DOI: 10.1155/2013/708391
5. Sundar S, Singh A, Chakravarty J, Rai M. Efficacy and safety of Miltefosine in treatment of post-kala-azar dermal Leishmaniasis. The Scientific World Journal. 2015;2015:1-6. Article ID: 414378. DOI: 10.1155/2015/414378
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献